Alkem Laboratories Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 2,91,015 shares,. Its Average Traded Price (ATP) is ₹5178.14, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 40 @ ₹5220.00.
Alkem Laboratories has an upper circuit limit of ₹5742.00 and a lower circuit limit of ₹4698.00. The total value traded stands at ₹150.69 CR, and the delivery percentage for the day is 66.6%.
The stock is currently traded with a market lot size of 1. Alkem Laboratories also offers a dividend yield of 1.01%.
Alkem Laboratories Share Price Chart
Alkem Laboratories Share Key Metrics
Volume
2.91 L
Market Cap
62412.93 CR
LTQ@LTP
40@5220.00
ATP
5178.14
Var Margin
12.5 %
Circuit Range
4698-5742
Delivery %
66.6 %
Value
150.69 CR
ASM/GSM
No
Market Lot
1
Alkem Laboratories Resistance and Support
Pivot 5191.67
Resistance
First Resistance
5248.34
Second Resistance
5333.17
Third Resistance
5389.84
Support
First Support
5106.84
Second Support
5050.17
Third Support
4965.34
Alkem Laboratories Futures & Options
5220
56.5 (1.09%)
Alkem Laboratories Option Chain
View Price, OI, Greeks & More...
27OCT26
5231.00
4.50 (0.09%)
23NOV26
5272.50
0.00 (0.00%)
29DEC26
5259.50
0.00 (0.00%)
ALKEM|27OCT26 CE 5200.00
152.60
37.35 (32.41%)
ALKEM|27OCT26 PE 5250.00
125
-38.85 (-23.71%)
Alkem Laboratories Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Alkem Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-28 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results & Interim Dividend |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-07 | Quarterly Results & Interim Dividend |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-08-07 | 2026-08-07 | View More |
Alkem Laboratories News
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Cessation
Alkem Laboratories announced the resignation of Chief Financial Officer Nitin Agrawal, effective September 30, 2026. Mr. Agrawal is departing to pursue new professional opportunities and will ensure a seamless handover.
Sep 24 2026 12:43:24
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Alkem Laboratories will host an in-person, one-on-one analyst/investor meeting with HDFC Mutual Fund on October 7, 2026. This meeting is part of routine investor relations and is subject to change.
Sep 23 2026 14:25:30
Alkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations
Alkem Laboratories has issued a corporate guarantee of Euro 54.45 million to HSBC UK Bank for a Euro 49.5 million term loan taken by its step-down subsidiary, Occlutech Holding AG, in Switzerland. This constitutes a contingent liability for Alkem if the subsidiary defaults on the loan.
Sep 21 2026 17:43:59
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alkem Laboratories launched NeuCeno (cenobamate), a new anti-seizure medication (ASM) for adult patients with partial-onset seizures. This 'first-in-India' launch addresses the significant healthcare burden of epilepsy, potentially transforming treatment outcomes.
Sep 16 2026 11:49:20
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alkem Laboratories announced the launch of Renocia Exo™, India's first patented Ginsenoside Exosome-based hair growth serum. This new generation therapy strengthens the company's dermatology portfolio by offering a multi-targeted approach to hair loss management.
Sep 08 2026 15:09:17
Alkem Laboratories Management
| Name | Position |
|---|---|
| Neela Bhattacherjee | Non Executive Independent Director |
| Manish Narang | President – Legal, Company Secretary & Compliance Officer |
Alkem Laboratories Similar Stocks
Aurobindo Pharma Ltd.
1676.80
4.80 (0.29%)
Max Healthcare Institute Ltd.
940.95
11.15 (1.20%)
Lupin Ltd.
2031.20
1.00 (0.05%)
Glenmark Pharmaceuticals Ltd.
2331.00
-3.70 (0.16%)
Aster DM Quality Care Ltd.
708.90
11.75 (1.69%)
Fortis Healthcare Ltd.
785.00
15.00 (1.95%)
Biocon Ltd.
370.70
0.40 (0.11%)
Abbott India Ltd.
26840.00
-285.00 (1.05%)
Gland Pharma Ltd.
2874.40
-25.00 (0.86%)
Alkem Laboratories FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in ALKEM
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC